![Ray Takigiku](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ray Takigiku was the founder of Bexion Pharmaceuticals, Inc., founded in 2006, and held the title of Chief Scientific Officer from 2022 to 2024.
Dr. Takigiku currently holds the position of Director at Sidis Corp.
Postes actifs de Ray Takigiku
| Sociétés | Poste | Début |
|---|---|---|
Sidis Corp
 Sidis Corp Financial ConglomeratesFinance Provides investment services for market-leading life science companies | Directeur/Membre du Conseil | - |
Anciens postes connus de Ray Takigiku
| Sociétés | Poste | Fin |
|---|---|---|
Bexion Pharmaceuticals, Inc.
 Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing drugs for curing cancer | Directeur Général | 02/02/2022 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Bexion Pharmaceuticals, Inc.
Bexion Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing drugs for curing cancer | Commercial Services |
Sidis Corp
Sidis Corp Financial ConglomeratesFinance Provides investment services for market-leading life science companies | Finance |
